This independent HPLC-UV/VIS lab test confirms PT-141 10mg from Certified Peptides at 99.22% purity with an actual assay of 12.04 mg. The analysis was performed by Vanguard Laboratory and reported on December 19, 2025, under Batch Number 2509PT-10.
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist researched for its role in sexual dysfunction treatment, melanocortin pathway activation, and libido enhancement. Additional testing confirmed endotoxin levels below 0.05 EU/mg (LAL method), sterility with no growth detected (USP <71>), and non-detectable levels of heavy metals including chromium, arsenic, cadmium, lead, and mercury via ICP-MS.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.